Second-generation antidepressant: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett |
imported>Robert Badgett No edit summary |
||
| Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
'''Second-generation | '''Second-generation [[antidepressant]]s''' are used to treat [[depression]] and are a "structurally and mechanistically diverse group of drugs that are not [[tricyclic antidepressant|tricyclics]] or [[monoamine oxidase inhibitor]]s. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake."<ref>{{MeSH|Second-generation antidepressants}}</ref> | ||
==Classification== | ==Classification== | ||
Second-generation | Second-generation antidepressants are classified by the [[biogenic amine receptor]] that they affect. | ||
===Selective serotonin reuptake inhibitors(SSRI)=== | ===Selective serotonin reuptake inhibitors(SSRI)=== | ||
* [[Fluoxetine]] | * [[Fluoxetine]] | ||
Revision as of 13:33, 25 February 2008
Second-generation antidepressants are used to treat depression and are a "structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake."[1]
Classification
Second-generation antidepressants are classified by the biogenic amine receptor that they affect.
Selective serotonin reuptake inhibitors(SSRI)
Serotonin 5-HT2–receptor agonist
Serotonin norepinephrine reuptake inhibitors (SNRI)
Norepinephrine uptake inhibitor
Dopamine reuptake inhibitor
References
- ↑ Anonymous (2024), Second-generation antidepressants (English). Medical Subject Headings. U.S. National Library of Medicine.